Hasbani Follows Up The Death Of Farah Kassab And Issues Two Decisions And Two Letters To The General

Hasbani Follows up the Death of Farah Kassab and Issues Two Decisions and Two Letters to the General Prosecution and the Order of Physicians

The Information Office of Deputy Prime Minister Health Minister Ghassan Hasbani issued the following statement:

In the context of following up the death of Farah Kassab after she underwent a cosmetic surgery in a specialized hospital in cosmetic surgeries,

Health Minister Ghassan Hasbani took the following actions:

The issuance of a decision on the prevention of surgical operations that require a general anesthetic in day hospitals or other cosmetic surgery clinics.
The issuance of a decision on the prevention of surgical operations that require a general anesthetic in Dr. Nader Saab hospital specialized in cosmetic surgery.
The issuance of a letter to the Public Prosecutor to investigate into the death of Farah Kassab.
The issuance of a letter to the Lebanese Order of Physicians in Beirut to conduct necessary investigations into the death of Farah Kassab, and give the Order a period of two weeks to clarify some technical medical points and answer questions asked by Health Minister concerning the death of the said woman.

These steps came to complete the immediate oral decision of Health Minister Ghassan Hasbani to cease operations in the said clinic after the woman's death, and the written decision issued Friday 2 June 2017 which stipulates the following:

Surgeries that may cause complications that require intensive care like liposuction and other surgeries shall not performed in places other than specialized hospitals which include an intensive care division that holds a license form Health Ministry in accordance with due process.
The doctor should explain to the patient the risks of the surgery, including the plastic surgery, and ask the patient to sign the Patient Right Form and the informed consent.

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01CE01	HYCAMTIN IV	B	Topotecan HCl - 4mg	4mg	Injectable lyophilised powder for solution	52,580,031 L.L
B02BD06	HAEMATE P	BioHuman	Von Willebrand Factor - 1200IU, Blood Coagulation Factor VIII - 500IU		Injectable lyophilised powder for solution+diluent	35,032,787 L.L
B02BD06	HAEMATE P	BioHuman	Von Willebrand Factor - 1200IU, Blood Coagulation Factor VIII - 500IU		Injectable lyophilised powder for solution+diluent	L.L
H02AB09	HYDROCORTISONE ORBUCELL	G	Hydrocortisone (sodium succinate) - 100mg	100mg	Injectable powder	1,091,712 L.L
L01FD01	HERZUMA	BioTech	Trastuzumab - 440mg	440mg	Injectable powder for concentrate for solution	89,046,707 L.L
L01FD01	HERZUMA	BioTech	Trastuzumab - 150mg	150mg	Injectable powder for concentrate for solution	36,113,036 L.L
B02BB01	HAEMOCOMPLETTAN P	BioHuman	Fibrinogen, human - 1g	1g	Injectable powder for solution	41,515,083 L.L
L01AA06	HOLOXAN	B	Ifosfamide - 1g	1g	Injectable powder for solution	3,586,850 L.L
B02BB01	HAEMOCOMPLETTAN P	BioHuman	Fibrinogen, human - 1g	1g	Injectable powder for solution	L.L
L01XX41	HALAVEN	B	Eribulin mesylate - 0.88mg/2ml	0.88mg/2ml	Injectable solution	35,421,768 L.L
M09AX01	HYALGAN	B	Hyaluronic acid (sodium) - 20mg/2ml	20mg/2ml	Injectable solution	3,407,985 L.L
J06BA02	HIZENTRA 1G	BioHuman	Immunoglobulin human - 1g/5ml	20%	Injectable solution	9,655,994 L.L
J06BA02	HIZENTRA 2G	BioHuman	Immunoglobulin human - 2g/10ml	20%	Injectable solution	18,441,015 L.L
N05CD08	HIKMA MIDAZOLAM	G	Midazolam (HCl) - 5mg/ml	5mg/ml	Injectable solution	679,984 L.L
J06BA02	HIZENTRA 4G	BioHuman	Immunoglobulin human - 4g/20ml	20%	Injectable solution	36,888,038 L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 60mg/0.4ml	60mg/0.4ml	Injectable solution	441,042,377 L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 30mg/ml	30mg/ml	Injectable solution	224,585,721 L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 150mg/ml	150mg/ml	Injectable solution	895,547,224 L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 105mg/0.7ml	105mg/0.7ml	Injectable solution	722,177,054 L.L
J01DB04	HIKMA CEFAZOLIN	G	Cefazolin (sodium) - 1g	1,000mg	Injectable solution	215,015 L.L
A10AB01	HUMULIN R U-100	BioTech	Insulin (human) - 100IU/ml	100IU/ml	Injectable solution	701,486 L.L
A10AB04	HUMALOG KWIKPEN	BioTech	Insulin lispro - 100IU/ml	100IU/ml	Injectable solution	3,950,897 L.L
M01AE03	HUMFINE	G	Ketoprofen - 100mg/2ml	100mg/2ml	Injectable solution	3,514,148 L.L
B05AA01	HUMAN ALBUMIN "OCTAPHARMA" 20%	BioHuman	Albumin human - 20%	20%	Injectable solution	4,863,366 L.L
B05AA01	HUMAN ALBUMIN 20% SOLUTION	BioHuman	Albumin human - 20%	20%	Injectable solution	4,343,343 L.L
N05AD01	HALDOL DECANOAS	B	Haloperidol (Decanoate) - 50mg/ml	50mg/ml	Injectable solution	444,812 L.L
B05AA01	HUMAN ALBUMIN BEHRING 20%, LOW SALT	BioHuman	Albumin human - 20%	20%	Injectable solution	4,343,343 L.L
L01XX41	HALAVEN	B	Eribulin mesylate - 0.88mg/2ml	0.88mg/2ml	Injectable solution	L.L
L04AB04	HUMIRA	BioTech	Adalimumab - 40mg/0.4ml	40mg/0.4ml	Injectable solution	L.L
B05XA03	HYPOTONIC SALINE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	149,393 L.L